tiprankstipranks
Genflow Biosciences Postpones Annual Report
Company Announcements

Genflow Biosciences Postpones Annual Report

Genflow Biosciences Plc (GB:GENF) has released an update.

Don't Miss our Black Friday Offers:

Genflow Biosciences Plc, a biotech firm specializing in longevity research, has announced the temporary suspension of its shares on the London Stock Exchange due to a delay in publishing its Annual Financial Report. The company assures that this delay, caused by a longer-than-expected audit process, does not reflect any issues with its economic position or cash flow. The suspension will allow Genflow additional time to finalize and disclose the report.

For further insights into GB:GENF stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskGenflow Biosciences Gains €4 Million for MASH Therapy
TipRanks UK Auto-Generated NewsdeskGenflow Biosciences Posts Promising Mid-Year Results
TipRanks UK Auto-Generated NewsdeskGenflow Biosciences Plc: AGM Success and Clinical Trials
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App